Literature DB >> 35701132

[Characteristics of amino acid metabolism in myeloid-derived suppressor cells in septic mice].

Y Ma1, Y Zhang2,3, R Li2,3, S W Deng2,3, Q S Qin1, L L Zhu1,2,3.   

Abstract

OBJECTIVE: To explore the amino acid metabolomics characteristics of myeloid-derived suppressor cells (MDSCs) in mice with sepsis induced by the cecal ligation and puncture (CLP).
METHODS: The sepsis mouse model was prepared by CLP, and the mice were randomly divided into a sham operation group (sham group, n = 10) and a CLP model group (n = 10). On the 7th day after the operation, 5 mice were randomly selected from the surviving mice in each group, and the bone marrow MDSCs of the mice were isolated. Bone marrow MDSCs were separated to measure the oxygen consumption rate (OCR) by using Agilent Seahorse XF technology and to detect the contents of intracellular amino acids and oligopeptides through ultra-performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) technology. Different metabolites and potential biomarkers were analyzed by univariate statistical analysis and multivariate statistical analysis. The major metabolic pathways were enriched using the small molecular pathway database (SMPDB).
RESULTS: The proportion of MDSCs in the bone marrow of CLP group mice (75.53% ± 6.02%) was significantly greater than that of the sham group (43.15%± 7.42%, t = 7.582, P < 0.001), and the basal respiratory rate [(50.03±1.20) pmol/min], maximum respiration rate [(78.07±2.57) pmol/min] and adenosine triphosphate (ATP) production [(25.30±1.21) pmol/min] of MDSCs in the bone marrow of CLP group mice were significantly greater than the basal respiration rate [(34.53±0.96) pmol/min, (t = 17.41, P < 0.001)], maximum respiration rate [(42.57±1.87) pmol/min, (t = 19.33, P < 0.001)], and ATP production [(12.63±0.96) pmol/min, (t = 14.18, P < 0.001)] of sham group. Leucine, threonine, glycine, etc. were potential biomarkers of septic MDSCs (all P < 0.05). The increased amino acids were mainly enriched in metabolic pathways, such as malate-aspartate shuttle, ammonia recovery, alanine metabolism, glutathione metabolism, phenylalanine and tyrosine metabolism, urea cycle, glycine and serine metabolism, β-alanine metabolism, glutamate metabolism, arginine and proline metabolism.
CONCLUSION: The enhanced mitochondrial oxidative phosphorylation, malate-aspartate shuttle and alanine metabolism in MDSCs of CLP mice may provide raw materials for mitochondrial aerobic respiration, thereby promoting the immunosuppressive function of MDSCs. Blocking the above metabolic pathways may reduce the risk of secondary infection in sepsis and improve the prognosis.

Entities:  

Keywords:  Aerobic respiration; Amino acid metabolomics; Myeloid-derived suppressor cell; Sepsis

Mesh:

Substances:

Year:  2022        PMID: 35701132      PMCID: PMC9197707     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  25 in total

1.  Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome.

Authors:  Juan C Mira; Lori F Gentile; Brittany J Mathias; Philip A Efron; Scott C Brakenridge; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

2.  Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer.

Authors:  Amir A Al-Khami; Paulo C Rodriguez; Augusto C Ochoa
Journal:  Oncoimmunology       Date:  2016-06-27       Impact factor: 8.110

3.  Malate-aspartate shuttle promotes l-lactate oxidation in mitochondria.

Authors:  Oya Altinok; Juan L Poggio; David E Stein; Wilbur B Bowne; Adrian C Shieh; Nathaniel W Snyder; Zulfiya Orynbayeva
Journal:  J Cell Physiol       Date:  2019-09-06       Impact factor: 6.384

4.  Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity.

Authors:  Cansu Cimen Bozkus; Bennett D Elzey; Scott A Crist; Lesley G Ellies; Timothy L Ratliff
Journal:  J Immunol       Date:  2015-10-21       Impact factor: 5.422

Review 5.  Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy.

Authors:  Barbara Wegiel; Marta Vuerich; Saeed Daneshmandi; Pankaj Seth
Journal:  Front Oncol       Date:  2018-08-13       Impact factor: 6.244

Review 6.  Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma.

Authors:  Woong-Jai Won; Jessy S Deshane; Jianmei W Leavenworth; Claudia R Oliva; Corinne E Griguer
Journal:  Cell Stress       Date:  2019-01-23

Review 7.  Myeloid-Derived Suppressor Cells: Ductile Targets in Disease.

Authors:  Francesca Maria Consonni; Chiara Porta; Arianna Marino; Chiara Pandolfo; Silvia Mola; Augusto Bleve; Antonio Sica
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

8.  β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME.

Authors:  Hemn Mohammadpour; Cameron R MacDonald; Philip L McCarthy; Scott I Abrams; Elizabeth A Repasky
Journal:  Cell Rep       Date:  2021-10-26       Impact factor: 9.423

9.  Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.

Authors:  Kristina E Rudd; Sarah Charlotte Johnson; Kareha M Agesa; Katya Anne Shackelford; Derrick Tsoi; Daniel Rhodes Kievlan; Danny V Colombara; Kevin S Ikuta; Niranjan Kissoon; Simon Finfer; Carolin Fleischmann-Struzek; Flavia R Machado; Konrad K Reinhart; Kathryn Rowan; Christopher W Seymour; R Scott Watson; T Eoin West; Fatima Marinho; Simon I Hay; Rafael Lozano; Alan D Lopez; Derek C Angus; Christopher J L Murray; Mohsen Naghavi
Journal:  Lancet       Date:  2020-01-18       Impact factor: 202.731

10.  Single-Cell RNA-seq of Human Myeloid-Derived Suppressor Cells in Late Sepsis Reveals Multiple Subsets With Unique Transcriptional Responses: A Pilot Study.

Authors:  Dijoia B Darden; Rhonda Bacher; Maigan A Brusko; Parker Knight; Russell B Hawkins; Michael C Cox; Marvin L Dirain; Ricardo Ungaro; Dina C Nacionales; Jaimar C Rincon; Marie-Pierre L Gauthier; Michael Kladde; Azra Bihorac; Todd M Brusko; Frederick A Moore; Scott C Brakenridge; Alicia M Mohr; Lyle L Moldawer; Philip A Efron
Journal:  Shock       Date:  2021-05-01       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.